Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Afongan
2. Cm 8282
3. Cm-8282
4. Fongamil
5. Fongarex
6. Omoconazole
7. Omoconazole Mononitrate
1. Omoconazole Nitrate [usan]
2. 83621-06-1
3. Omoconazole Mononitrate
4. 15lty5sty6
5. 1h-imidazole, 1-(2-(2-(4-chlorophenoxy)ethoxy)-2-(2,4-dichlorophenyl)-1-methylethenyl)-, (z)-, Mononitrate
6. Fongarex
7. 1-[(z)-1-[2-(4-chlorophenoxy)ethoxy]-1-(2,4-dichlorophenyl)prop-1-en-2-yl]imidazole;nitric Acid
8. Unii-15lty5sty6
9. Anfongan
10. Fangorex
11. Fongamil
12. Omotrex
13. Afonga
14. Omoconazolnitrat
15. Ccris 8167
16. (z)-1-(2,4-dichloro-beta-(2-(p-chlorophenoxy)ethoxy)-alpha-methylstyryl)imidazole Mononitrate
17. (z)-1-(2-(2-(4-chlorophenoxy)ethoxy)-2-(2,4-dichlorophenyl)-1-methylethenyl)-1h-imidazole Hno3
18. Schembl1643133
19. Schembl1643135
20. Sgd-12878
21. Chembl2107140
22. Omoconazole Nitrate [mi]
23. Chebi:31935
24. Omoconazole Nitrate (jan/usan)
25. Hoc-155
26. Omoconazole Nitrate [jan]
27. Omoconazole Nitrate [mart.]
28. Omoconazole Nitrate [who-dd]
29. Cm-8282
30. D01664
31. Q27251733
32. (z)-1-(2,4-dichloro-.beta.-(2-(p-chlorophenoxy)ethoxy)-.alpha.-methylstyryl)imidazole Mononitrate
| Molecular Weight | 486.7 g/mol |
|---|---|
| Molecular Formula | C20H18Cl3N3O5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | 485.031204 g/mol |
| Monoisotopic Mass | 485.031204 g/mol |
| Topological Polar Surface Area | 102 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 522 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
Market Place
ABOUT THIS PAGE
A Omoconazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Omoconazole, including repackagers and relabelers. The FDA regulates Omoconazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Omoconazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Omoconazole supplier is an individual or a company that provides Omoconazole active pharmaceutical ingredient (API) or Omoconazole finished formulations upon request. The Omoconazole suppliers may include Omoconazole API manufacturers, exporters, distributors and traders.
click here to find a list of Omoconazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Omoconazole DMF (Drug Master File) is a document detailing the whole manufacturing process of Omoconazole active pharmaceutical ingredient (API) in detail. Different forms of Omoconazole DMFs exist exist since differing nations have different regulations, such as Omoconazole USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Omoconazole DMF submitted to regulatory agencies in the US is known as a USDMF. Omoconazole USDMF includes data on Omoconazole's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Omoconazole USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Omoconazole suppliers with USDMF on PharmaCompass.
Omoconazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Omoconazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Omoconazole GMP manufacturer or Omoconazole GMP API supplier for your needs.
A Omoconazole CoA (Certificate of Analysis) is a formal document that attests to Omoconazole's compliance with Omoconazole specifications and serves as a tool for batch-level quality control.
Omoconazole CoA mostly includes findings from lab analyses of a specific batch. For each Omoconazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Omoconazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Omoconazole EP), Omoconazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Omoconazole USP).
LOOKING FOR A SUPPLIER?
